- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of the current proposal is to assess, in a phase 1/2 study, the safety and efficacy of a synthetic vaccine SLP-HPV-01® in HIV+ men with CD4 counts > 350 x 10E6/l and intra-anal high-grade, HPV16 positive AIN, who failed on previous treatment.
Critère d'inclusion
- HPV16-induced intra-anal high-grade AIN (grade 2-3) in HIV+ men, that was resistant to, or recurred after conventional cauterization or other forms of local treatment